GLP-1 medications , or glucagon-like peptide-1 compounds, represent a substantial innovation in how we treat diabetes mellitus . These prescription medications function to imitating the body’s own GLP-1 substance , which promotes blood sugar control and diminishes glucagon secretion . Beyond blood sugar levels control , trials show that GLP-1 med